188 related articles for article (PubMed ID: 1624542)
21. Effect of various oxygenation conditions and fluosol-DA on cytotoxicity and antitumor activity of bleomycin in mice.
Teicher BA; Holden SA; Cathcart KN; Herman TS
J Natl Cancer Inst; 1988 Jun; 80(8):599-603. PubMed ID: 2453675
[TBL] [Abstract][Full Text] [Related]
22. Classification of antineoplastic treatments by their differential toxicity toward putative oxygenated and hypoxic tumor subpopulations in vivo in the FSaIIC murine fibrosarcoma.
Teicher BA; Holden SA; al-Achi A; Herman TS
Cancer Res; 1990 Jun; 50(11):3339-44. PubMed ID: 2334928
[TBL] [Abstract][Full Text] [Related]
23. Combination of perfluorochemical emulsions and carbogen breathing with cancer chemotherapy.
Teicher BA
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1109-20. PubMed ID: 7849913
[TBL] [Abstract][Full Text] [Related]
24. Differential enhancement of melphalan cytotoxicity in tumor and normal tissue by Fluosol-DA and oxygen breathing.
Teicher BA; Holden SA; Rose CM
Int J Cancer; 1985 Nov; 36(5):585-9. PubMed ID: 3932225
[TBL] [Abstract][Full Text] [Related]
25. Optimization of perfluorochemical levels with radiation therapy in mice.
Teicher BA; Herman TS; Jones SM
Cancer Res; 1989 May; 49(10):2693-7. PubMed ID: 2713854
[TBL] [Abstract][Full Text] [Related]
26. Combination of etanidazole with cyclophosphamide and platinum complexes.
Teicher BA; Herman TS; Shulman L; Bubley G; Coleman CN; Frei E
Cancer Chemother Pharmacol; 1991; 28(3):153-8. PubMed ID: 1830248
[TBL] [Abstract][Full Text] [Related]
27. Potentiation of rat brain tumor therapy by fluosol and carbogen.
Martin DF; Kimler BF; Evans RG; Morantz RA; Vats TS
NCI Monogr; 1988; (6):119-22. PubMed ID: 3127732
[TBL] [Abstract][Full Text] [Related]
28. Effect of Fluosol-DA/O2 on the antitumor activity and pulmonary toxicity of bleomycin.
Teicher BA; Lazo JS; Merrill WW; Filderman AE; Rose CM
Cancer Chemother Pharmacol; 1986; 18(3):213-8. PubMed ID: 2433068
[TBL] [Abstract][Full Text] [Related]
29. Evidence for macrophage involvement in the enhancement of tumor growth delay with X-ray/Fluosol-DAR/O2 combination therapy.
Holden SA; Teicher BA; McIntosh NL; Rose CM
Anticancer Res; 1987; 7(3 Pt B):385-90. PubMed ID: 3115174
[TBL] [Abstract][Full Text] [Related]
30. New high O2 carrying perfluorochemical emulsions and/or carbogen: reactions of a human tumor xenograft to irradiation.
Thomas C; Lartigau E; Malaise EP; Guichard M
Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1157-60. PubMed ID: 2497094
[TBL] [Abstract][Full Text] [Related]
31. Reactions of tumors and normal tissues in mice to irradiation in the presence and absence of a perfluorochemical emulsion.
Rockwell S; Mate TP; Irvin CG; Nierenburg M
Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1315-8. PubMed ID: 3093416
[TBL] [Abstract][Full Text] [Related]
32. Effect of novobiocin on the antitumor activity and tumor cell and bone marrow survivals of three alkylating agents.
Eder JP; Teicher BA; Holden SA; Cathcart KN; Schnipper LE; Frei E
Cancer Res; 1989 Feb; 49(3):595-8. PubMed ID: 2910481
[TBL] [Abstract][Full Text] [Related]
33. Enhancement of alkylating agent activity by SR-4233 in the FSaIIC murine fibrosarcoma.
Holden SA; Teicher BA; Ara G; Herman TS; Coleman CN
J Natl Cancer Inst; 1992 Feb; 84(3):187-93. PubMed ID: 1542129
[TBL] [Abstract][Full Text] [Related]
34. Modification of photodynamic therapy-induced hypoxia by fluosol-DA (20%) and carbogen breathing in mice.
Fingar VH; Mang TS; Henderson BW
Cancer Res; 1988 Jun; 48(12):3350-4. PubMed ID: 3130983
[TBL] [Abstract][Full Text] [Related]
35. Modulation of alkylating agents by lonidamine in vivo.
Teicher BA; Holden SA; Herman TS; Frei E
Semin Oncol; 1991 Apr; 18(2 Suppl 4):7-10. PubMed ID: 1903216
[TBL] [Abstract][Full Text] [Related]
36. CAI: effects on cytotoxic therapies in vitro and in vivo.
Teicher BA; Holden SA; Chen YN; Ara G; Korbut TT; Northey D
Cancer Chemother Pharmacol; 1994; 34(6):515-21. PubMed ID: 7923563
[TBL] [Abstract][Full Text] [Related]
37. Effect of oxygen on the cytotoxicity and antitumor activity of etoposide.
Teicher BA; Holden SA; Rose CM
J Natl Cancer Inst; 1985 Dec; 75(6):1129-33. PubMed ID: 3934448
[TBL] [Abstract][Full Text] [Related]
38. Administration of a perfluorochemical emulsion plus carbogen breathing does not alter radiation pneumonitis.
Rockwell S; Kelley M; Rosiello RA; Merrill WW; Carter D
Proc Soc Exp Biol Med; 1995 Mar; 208(3):288-93. PubMed ID: 7878068
[TBL] [Abstract][Full Text] [Related]
39. Use of perfluorochemical emulsions in cancer therapy.
Teicher BA
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):875-82. PubMed ID: 1391527
[TBL] [Abstract][Full Text] [Related]
40. [Minimal effective dose of perfluorochemical emulsion as a radiosensitizer].
Hishikawa-Itoh Y; Kato T; Niwa T; Ayakawa Y; Miyata N
Nihon Gan Chiryo Gakkai Shi; 1989 Jun; 24(6):1243-8. PubMed ID: 2794648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
